VCYT NASDAQ
Veracyte, Inc.
1W: +16.2%
1M: +34.1%
3M: +26.8%
YTD: +6.6%
1Y: +56.9%
3Y: +83.8%
5Y: +23.6%
$45.03
-0.16 (-0.35%)
Weekly Expected Move ±13.5%
$28
$33
$38
$44
$49
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.90
Bullish
1 bullish
0 neutral
0 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (59)
Why Veracyte (VCYT) is a Top Growth Stock for the Long-Term
Why Veracyte Stock Is Skyrocketing Higher This Week
Veracyte (VCYT) Crossed Above the 200-Day Moving Average: What That Means for Investors
12 Health Care Stocks Moving In Wednesday's Intraday Session
Veracyte (VCYT) Beats Q1 Earnings and Revenue Estimates
Veracyte, Inc. Q1 2026 Earnings Call Summary
Veracyte (VCYT) Q1 2026 Earnings Transcript
Full Transcript: Veracyte Q1 2026 Earnings Call
Wall Street Analysts Think Veracyte (VCYT) Could Surge 39.16%: Read This Before Placing a Bet
Earnings Scheduled For May 5, 2026
Tactile Systems Technology (TCMD) Reports Q1 Loss, Tops Revenue Estimates
Veracyte (VCYT) Recently Broke Out Above the 50-Day Moving Average
If You Invested $1000 in Veracyte a Decade Ago, This is How Much It'd Be Worth Now
AEGON ASSET MANAGEMENT UK Plc Has $20.60 Million Position in Veracyte, Inc. $VCYT
Veracyte, Inc. (NASDAQ:VCYT) Receives Consensus Recommendation of “Hold” from Analysts
Cathie Wood's ARK boosts Palantir, Tesla, Roninhood bets; cuts semiconductor exposure
Veracyte (NASDAQ:VCYT) Stock Price Crosses Below 200 Day Moving Average – Here’s Why
Cathie Wood's weekly moves signal shift to AI, precision medicine
Is Veracyte Stock the Right Pick for Your Portfolio Now?
Cathie Wood's Ark Invest in broad sell-off; trims AI, crypto, internet names
Exchange Traded Concepts LLC Reduces Stock Position in Veracyte, Inc. $VCYT
Veracyte (VCYT) Down 15.4% Since Last Earnings Report: Can It Rebound?
Veracyte, Inc. (NASDAQ:VCYT) Given Average Recommendation of “Hold” by Brokerages
Bamco Inc. NY Decreases Stake in Veracyte, Inc. $VCYT
Veracyte, Inc. $VCYT is ArrowMark Colorado Holdings LLC’s 7th Largest Position
Marc Stapley Sells 45,523 Shares of Veracyte (NASDAQ:VCYT) Stock
Veracyte, Inc. $VCYT Shares Acquired by ARK Investment Management LLC
Amova Asset Management Americas Inc. Sells 165,094 Shares of Veracyte, Inc. $VCYT
OGN's VTAMA Cream Shows Sleep Benefits in Pediatric Atopic Dermatitis
GEHC & UCSF Form 10-Year Alliance to Advance Imaging & Care Delivery
Artisan Partners Limited Partnership Acquires 1,048,692 Shares of Veracyte, Inc. $VCYT
Veracyte Q4 Earnings Beat Estimates, Revenues Grow Y/Y, Stock Rises
Veracyte outlines 10%–13% revenue growth for 2026 while advancing MRD and Prosigna launches
Veracyte, Inc. (VCYT) Q4 2025 Earnings Call Transcript
Veracyte Non-GAAP EPS of $0.53 beats by $0.12, revenue of $140.6M beats by $4.81M
Veracyte (VCYT) Q4 Earnings and Revenues Surpass Estimates
Veracyte Announces Fourth Quarter and Full Year 2025 Financial Results
Veracyte to Highlight Extensive Decipher® Data at 2026 ASCO GU Symposium
Veracyte (VCYT) is a Top-Ranked Growth Stock: Should You Buy?
Here's How Veracyte Stock Is Placed Ahead of Q4 Earnings
Veracyte (VCYT) Loses 20.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Veracyte to Release Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026
Here's Why Veracyte (VCYT) is a Strong Growth Stock
Here's Why Veracyte (VCYT) Is a Great 'Buy the Bottom' Stock Now
Veracyte, Inc. $VCYT Shares Purchased by Amalgamated Bank
Why Veracyte (VCYT) is Poised to Beat Earnings Estimates Again
Why Veracyte (VCYT) is a Top Momentum Stock for the Long-Term
Oregon Public Employees Retirement Fund Takes $608,000 Position in Veracyte, Inc. $VCYT
Veracyte: Profitable, De-Risked, And Ready To Run
Veracyte, Inc. (VCYT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Veracyte Announces Preliminary Fourth Quarter and Full-Year 2025 Results
Veracyte to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Veracyte, Inc. $VCYT Shares Sold by Assenagon Asset Management S.A.
Is This the Right Time to Add Veracyte Stock to Your Portfolio?
Fisher Asset Management LLC Reduces Holdings in Veracyte, Inc. $VCYT
Why Veracyte (VCYT) is a Top Growth Stock for the Long-Term
Head to Head Review: Veracyte (NASDAQ:VCYT) vs. Nanovibronix (NASDAQ:NAOV)
Advantage Alpha Capital Partners LP Sells 7,161 Shares of Veracyte, Inc. $VCYT
AXQ Capital LP Buys New Shares in Veracyte, Inc. $VCYT